Journal retracts note of concern after court settles authorship dispute

A journal has retracted a warning posted to a paper involved in an authorship dispute, after the issue was resolved in a court case.

In an editorial published Jan. 10, editors at the journal Molecules wrote that they were removing the expression of concern for “Helleborus purpurascens—Amino Acid and Peptide Analysis Linked to the Chemical and Antiproliferative Properties of the Extracted Compounds.”

The editors flagged the 2015 paper in June, 2016 after a researcher in Germany also claimed authorship. In the 2016 notice, the editors wrote:

Continue reading Journal retracts note of concern after court settles authorship dispute

Caught Our Notice: An article about repetition is duplicated? Priceless

Title: Does repetition help? Impact of destination promotion videos on perceived destination image and intention-to-visit change

What Caught Our Attention: At times we get to just appreciate the moment: A paper focused on repetition — specifically, linking repeated exposure to travel videos and actual visits to the location — got retracted for duplication.  The notice says the duplications were “inadvertent;” perhaps these researchers were motivated by their research? This isn’t the first time authors have been tripped up by their own subjects — in 2015, a researcher retracted his guidelines on plagiarism for…you guessed it. (Plagiarism.) Continue reading Caught Our Notice: An article about repetition is duplicated? Priceless

Weekend reads: What’s wrong with peer review; a retraction poem; how journal formats mangle science

The week at Retraction Watch featured the retraction of a paper on the effects of fracking, authors who retracted a paper when they realized they’d been studying the wrong species, and a story about why a paper linked to an alleged doping scandal in Norway was retracted. Here’s what was happening elsewhere:

Continue reading Weekend reads: What’s wrong with peer review; a retraction poem; how journal formats mangle science

Second paper tied to drug scandal in Norway ski team retracted

Researchers in Norway have retracted a second high-profile exercise paper — again after running afoul of an ethical approval committee.

As part of the 2016 study, the researchers gave athletes asthma medication to measure its effect on signals from the nervous system to the lungs; although the drug appeared to have no detectable effect on the nervous system signals, 45 minutes after getting the drug, athletes (including those without asthma) showed an average slight increase in one measure of lung function.

Annette Birkeland, of The Norwegian National Research Ethics Committees (FEK), told us:

Continue reading Second paper tied to drug scandal in Norway ski team retracted

Journal retracts paper after discovering lead author forged co-author’s signature

A pharmacy journal has retracted a 2017 cancer paper after determining that the lead author forged her co-author’s signature.

Alain Li Wan Po, editor-in-chief of the Journal of Clinical Pharmacy and Therapeutics, told Retraction Watch that, after discovering the forgery, the journal lost confidence in “the integrity of the whole report,” and decided to retract it:

Our judgment was that if an author is willing to forge a signature, we cannot be sure of the integrity of the whole report and decided on the retraction.

According to Po, the paper’s lead author, Yan Wang, objected to the retraction because “she maintained that the data were accurate.” So the editors retracted the paper without her approval — but with the agreement of the author Jatinder Lamba, whose name was forged.

How did the journal discover the forged signature?

Continue reading Journal retracts paper after discovering lead author forged co-author’s signature

Caught Our Notice: Oops, wrong species

Title: Virulent Diuraphis noxia Aphids Over-Express Calcium Signaling Proteins to Overcome Defenses of Aphid-Resistant Wheat Plants

What Caught Our Attention: Sadly, it’s not uncommon for researchers to mistake the identity of what they’re working with — but not everyone comes clean and works to transparently correct the record. So it’s nice to see some authors among a group based in the US and India take the initiative to retract their paper after realizing they had based some of their conclusions on the wrong species of aphid. Continue reading Caught Our Notice: Oops, wrong species

“GOOD NEWS!…we were able to retract your article:” Journal

A paleontology journal has retracted a recent paper after discovering it had published the uncorrected version of the manuscript.

The mistake occurred after the authors submitted revisions to the manuscript without tracking the changes, prompting the publisher to believe nothing had been changed and publishing the previous version. The journal initially told the authors it planned to publish an erratum that described the mistake as a production error, but then retracted the paper—seemingly without consulting the authors. However, the authors said they were happy with the outcome.

Glenn Brock, an author on the Journal of Paleontology paper, told Retraction Watch: Continue reading “GOOD NEWS!…we were able to retract your article:” Journal

Questions swirl around CNRS director’s decision to step down early

Anne Peyroche

Today, a French council was set to confirm the new head of a prominent research institute, the National Center for Scientific Research (CNRS). But the appointee took the job a few days early, after the interim director stepped down last week — and the speculation about why she left hasn’t stopped ever since.

An official announcement from the French Ministry of Higher Education, Research and Innovation, which runs the CNRS, said Anne Peyroche would be replaced by her expected successor, computer scientist Antoine Petit. Although there have been discussions about some of Peyroche’s work on PubPeer (some of which the authors have responded to, assuaging at least one critic), the announcement provided no reason for the new timetable; a news story in Le Figaro cited health reasons.

A spokesperson for the CNRS told Retraction Watch:

Continue reading Questions swirl around CNRS director’s decision to step down early

“The most terrible experience of my life:” Authorship dispute leads to lawsuit

A journal has retracted a 2014 paper because of an authorship dispute that became the subject of litigation.

Last year, the Allegheny Health Network in Pittsburgh requested the paper be retracted to resolve the dispute. The Journal of Applied Biomaterials & Functional Materials retracted the paper in October.

According to the retraction notice, the principal investigator of a clinical trial on which some of the study is based was not included as a co-author, and claimed he had not “validated the accuracy of the data.”

The notice does not mention a lawsuit, but a letter from the authors’ research institution does.

Continue reading “The most terrible experience of my life:” Authorship dispute leads to lawsuit

Researcher at Japan stem cell institute falsified nearly all images in 2017 paper

Shinya Yamanaka

An investigation by Kyoto University in Japan has found a researcher guilty of falsifying all but one of the figures in a 2017 stem cell paper.

Yesterday, Kyoto University announced that the paper’s first author, Kohei Yamamizu, had fabricated and falsified data in the Stem Cell Reports paper. According to the investigation report, none of the other authors were involved in the data manipulation.

Yamamizu works at the Center for iPS cell Research and Application (CiRA) at Kyoto University, directed by Shinya Yamanaka, a Nobel Prize winner for his pioneering work in stem cell biology.

A spokesperson for the journal told us that the authors disclosed the problems last week and Stem Cell Reports will be retracting the paper, published last February.

In the university’s official statement, Yamanaka said: Continue reading Researcher at Japan stem cell institute falsified nearly all images in 2017 paper